144Filing Date: Sep 8, 2026
Resmed (RMD)
Insider Proposed Sale Notice
View SEC Filing
ACC: 0001959173-26-006784
Sale Plan
Farrell Michael J.
Officer, Director·Resmed
Proposed
CommonNYSE
Shares4.99K
Est. DateSep 8
Market Value$1.13M
BrokerFidelity Brokerage Services LLC
AcquisitionStock Option Exercise · Issuer
Acquired DateSep 8, 2026
Amount Acquired4.99K
10b5-1 Plan Adoption10/31/2024
% Outstanding0.0035%
10b5-1
Exercise / Payment Details
Paid: Sep 8, 2026Method: Cash
Sales Past 3 Months Total $3.09M · 14.97K sh. expand_more
Aug
7
$1.03M
4.99K sh.
Jul
7
$1.09M
4.99K sh.
Jun
8
$968.1K
4.99K sh.
Signature & Compliance expand_more
Notice DateSep 8, 2026
10b5-1 Plan Adoption10/31/2024
Signature /s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Farrell
Issuer Info expand_more
CompanyRESMED INC
CIK0000943819
SEC File No.001-15317
Phone8587462400
Address9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA 92123